Exosomes, PRP and Growth Factors Around a Facelift: What the Evidence Shows

14 hours ago

5 min read

Almost every clinic now offers something regenerative alongside surgery: exosomes, platelet-rich plasma, growth factor serums, polynucleotides. The marketing is confident. The published evidence is more modest than the marketing, and worth knowing before you pay for an add-on.

Deep plane facelift before and after
Deep plane facelift before and after
Deep plane facelift before and one year after

Quick answer

Human trials of exosome treatments report measurable but moderate improvements in skin quality, with an average wrinkle reduction of about 20% in a recent meta-analysis of 39 studies. The level of evidence is low to moderate, protocols are not standardised and manufacturing is not consistently regulated. These treatments work on skin quality; they do not reposition tissue and are not an alternative to surgery.

What exosomes are

Exosomes are very small vesicles released by cells. They carry proteins and genetic material and act as a messaging system between cells. In skin treatment the idea is that applying them stimulates collagen and elastin production and reduces inflammation.

The products used commercially differ widely in their source, in how they are processed and in what they actually contain, which is one reason trial results vary.

What the published studies report

According to PubMed, three reviews published recently give a reasonable picture.

A systematic review and meta-analysis of 39 human trials in aesthetic medicine, 26 on skin and 13 on hair, found average wrinkle reduction of 20.2% (95% confidence interval 15.3% to 25.2%), improvements of 14.7% to 23.4% across pigmentation, elasticity, texture, redness and overall appearance, and hair density and thickness improvements of 23.6% and 18.0%. The authors assigned a level of evidence of 3 and noted that non-standardised protocols limit generalisability (Stack and colleagues, Aesthetic Surgery Journal, 2026).
A systematic review of 21 studies on skin rejuvenation reported consistent improvements in elasticity, wrinkle depth, hydration and pigmentation with favourable safety, while concluding that larger standardised trials with longer follow-up are still needed (Alzahrani and colleagues, Dermatology Practical and Conceptual, 2026).
A systematic review focused on hair restoration found early clinical studies reporting 8% to 20% improvement in hair density, but described the evidence base as limited by small samples, retrospective designs and absent control groups, and identified manufacturing standardisation and regulation as critical gaps (Malih and colleagues, Molecular Biology Reports, 2026).

How to read those numbers

A 20% reduction in wrinkle depth is a real measurement, and it is also a change most people would describe as subtle rather than transformative. It is the kind of improvement that shows on standardised photography and in instrument measurements, not the kind that makes someone look like a different person.

Level of evidence 3 means the findings come mainly from non-randomised studies. That is not the same as no evidence, and it is not the same as proof.

Where these treatments genuinely fit

Skin quality. Texture, fine lines, pigmentation and redness. This is where the measured effects are.
Alongside surgery, not instead of it. Lifting repositions tissue; regenerative treatments do not. The two address different problems, as explained in our article on what a facelift can and cannot change.
Hair. The data here are no stronger, but the alternatives are also limited, which changes the balance for some patients.

Questions that separate a good offer from a weak one

What is the product, and what is the source material?
Where is it manufactured and under what quality standard?
What human studies exist for this specific use, and what effect size did they report?
How many sessions, at what interval, and what happens when they stop?
What is the cost per session, and what would the same money buy elsewhere in my plan?

An honest position

These treatments are not a scam and they are not a substitute for surgery. They are an early-stage field with real but moderate measured effects, inconsistent products and incomplete regulation. If you want skin quality improvement and understand the size of the effect, they are a reasonable choice. If what has changed in your face is position rather than quality, no serum will address it, and our deep plane facelift page explains what does.

Frequently Asked Questions

Do exosomes have any published clinical evidence?

Yes, although it is early. According to PubMed, a systematic review and meta-analysis of 39 human trials reported an average facial wrinkle reduction of 20.2% (95% confidence interval 15.3% to 25.2%) and improvements of 14.7% to 23.4% in pigmentation, elasticity, texture, redness and overall appearance. The authors rated the level of evidence as 3 and noted that heterogeneity and non-standardised protocols limit how far the findings generalise (DOI).

Are exosome products regulated?

Regulation varies by country and is one of the open problems in this field. Reviews repeatedly identify gaps in manufacturing standardisation, scalability and regulatory frameworks as the main barriers to wider adoption (DOI). Ask what the specific product is, where it is made and under what standard.

Can exosomes replace a facelift?

No. The measured outcomes in published trials are skin quality measures: wrinkle depth, elasticity, pigmentation, texture. None of these studies report repositioning of descended tissue, which is what a facelift does.

What about PRP?

Platelet-rich plasma is prepared from the patient’s own blood, which removes the product-sourcing problem. It is used in this clinic for skin quality and hair, and the details are on our PRP treatment page. Like exosomes it works on tissue quality rather than position.

Do these treatments speed up healing after surgery?

That is a common claim and it is not yet supported by strong trial evidence in facelift patients specifically. The reviews that exist measure skin appearance outcomes, not post-surgical recovery times.

How should I judge an offer I am given?

Ask three questions: what exactly is in the product, what human trial data exist for this specific indication, and what the measured size of the effect is. An answer in percentages with a citation is a good sign; an answer in adjectives is not.

About the Author

This article was written and medically reviewed by Prof. Dr. Suleyman Tas, a plastic, reconstructive and aesthetic surgeon in Istanbul with over 20 years of experience. He is the author of Rhinoplasty in Practice (CRC Press, 2020), has more than 40 peer-reviewed scientific publications and five patents, and teaches facelift and rhinoplasty techniques to surgeons at international courses. Read more about Prof. Dr. Suleyman Tas.

Individual results vary. Before and after photos and videos are shared with patient consent. This article is for general information and does not replace a personal medical consultation.

See More Before and After Results

Would You Like a Similar Result?

You can send your photos for an online assessment or book an appointment at the Prof. Dr. Suleyman Tas Clinic, Terrace Fulya, Şişli, Istanbul. Book an online consultation.